Trevi Therapeutics Inc

0.00 (-0.16%)
Earnings Announcements

Trevi Therapeutics Reports Q3 2020 Financial Results

Published: 11/11/2020 21:26 GMT
Trevi Therapeutics Inc (TRVI) - Trevi Therapeutics Announces Third Quarter 2020 Financial Results and Business Update.
Trevi Therapeutics Inc - Cash Position Expected to Fund Operations Into First Half of 2022.
Trevi Therapeutics Inc - As of September 30, 2020, Co Had Total Cash and Cash Equivalents of $53.3 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.51

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.48

More details on our Analysts Page.